Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

11.230
+0.0400.36%
Volume:3.03M
Turnover:34.11M
Market Cap:29.15B
PE:34.14
High:11.370
Open:11.310
Low:11.160
Close:11.190
52wk High:15.080
52wk Low:6.955
Shares:2.60B
HK Float Shares:2.60B
Volume Ratio:0.93
T/O Rate:0.12%
Dividend:0.17
Dividend Rate:1.56%
EPS(LYR):0.329
ROE:12.45%
ROA:6.50%
PB:3.55
PE(LYR):34.14
PS:3.62

Loading ...

BRIEF-Simcere Pharmaceutical Enters Exclusive Licensing Agreement With Boehringer Ingelheim

Reuters
·
Jan 27

SIMCERE PHARMA (02096) Signs Exclusive Licensing Agreement with Boehringer Ingelheim for SIM0709 (TL1A/IL-23p19 Bispecific Antibody)

Stock News
·
Jan 27

Simcere Signs Exclusive Global Licensing Agreement With Boehringer Ingelheim for SIM0709

Reuters
·
Jan 27

Simcere Pharmaceutical - Eligible for EUR42 Mln Upfront and up to EUR1,016 Mln in Milestones

THOMSON REUTERS
·
Jan 27

Simcere Pharmaceutical - Boehringer Ingelheim Granted Exclusive Rights to Sim0709 Outside Greater China

THOMSON REUTERS
·
Jan 27

SIMCERE PHARMA (02096) Repurchases 862,000 Shares for HK$10.04 Million on January 22

Stock News
·
Jan 22

SIMCERE PHARMA (02096) Repurchases 1.884 Million Shares for HK$22.21 Million on January 20

Stock News
·
Jan 20

SIMCERE PHARMA (02096) Repurchases 4.433 Million Shares for HK$51.6328 Million on January 16

Stock News
·
Jan 16

Simcere Pharmaceutical Group Limited (HKG:2096) Shares Could Be 48% Below Their Intrinsic Value Estimate

Simply Wall St.
·
Jan 16

SIMCERE PHARMA (02096) Repurchases 3.672 Million Shares for HK$41.9453 Million on January 12

Stock News
·
Jan 12

Simcere Pharmaceutical to Spin Off, List Chinese Subsidiary; Shares Down 7%

MT Newswires Live
·
Jan 12

HKEX Announcement Highlights | Simcere Pharma Plans to Spin Off Simcere Ming's H Shares for Separate Listing on Main Board

Stock News
·
Jan 11

BRIEF-Simcere Pharmaceutical Announces Spin-Off & Separate Listing Of Simcere Zaiming Pharmaceutical

Reuters
·
Jan 10

SIMCERE PHARMA (02096) Plans to Spin Off SIMCERE RENMING's H Shares for Separate Listing on SEHK Main Board

Stock News
·
Jan 09

Simcere Pharmaceutical - Upon Completion, Co Expected to Have Interest of Over 50% in Simcere Zaiming

THOMSON REUTERS
·
Jan 09

Guojin Securities Initiates Coverage on Simcere Pharma (02096) with "Buy" Rating, Targets HK$20.16

Stock News
·
Dec 29, 2025

Securing a $7.4 Billion Mega-Deal, $17 Billion Pharma Tycoon Ren Jinsheng is on a Winning Streak

Deep News
·
Dec 25, 2025

Simcere Pharma Gets China Nod for Tumor Drug Trial

MT Newswires Live
·
Dec 23, 2025

SIMCERE PHARMA (02096): SIM0610 (EGFR/cMET Bispecific Antibody-Drug Conjugate) Receives Clinical Trial Approval from NMPA

Stock News
·
Dec 23, 2025

Simcere Pharmaceutical - Sim0610 Receives Clinical Trial Approval From Nmpa China

THOMSON REUTERS
·
Dec 23, 2025